awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26996629-7FCB62C0-3A6A-4299-AA97-38AB6DD1A28B
Q26996629-7FCB62C0-3A6A-4299-AA97-38AB6DD1A28B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26996629-7FCB62C0-3A6A-4299-AA97-38AB6DD1A28B
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma
P2860
Q26996629-7FCB62C0-3A6A-4299-AA97-38AB6DD1A28B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26996629-7FCB62C0-3A6A-4299-AA97-38AB6DD1A28B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be69cbad2d5ac08e764d1c5c0cd999cd32145663
P2860
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.